Online identity verification platform Are You A Human has been acquired by Distil Networks, allowing corporate venturing unit MDC Dream Ventures to exit.

Bioverativ could end up paying $825m for rare disease drug developer True North, which had raised $142m from backers including GlaxoSmithKline, Biogen Idec, Baxter and Baxalta.

SoftBank, already a 33% shareholder, has reportedly acquired the stakes of three other Snapdeal board members, and Flipkart has signed a term sheet to buy it for a price that could be under $1bn.

Wells Fargo has exited alternative investments analysis platform AltX in an acquisition by financial software producer Addepar.

The enterprise software company has invested an undisclosed sum in automated HR app creator BuildOnMe and acquired another artificial intelligence tool developer, Qlue.

VMware has acquired one of its portfolio companies, app performance management platform Apteligent, in a deal that also gave exits to Alphabet, AOL and Accenture.

The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.

HTC, Qualcomm and Colopl have exited virtual reality game developer Owlchemy in an acquisition of undisclosed size by Google.

Bruker has acquired Luxendo, a spinout of the European Molecular Biology Laboratory that closed an $8.4m series A round in January.